NSE:SPARC Revenue

In the fiscal year ending March 31, 2025, Sun Pharma Advanced Research Company had annual revenue of 717.70M INR, down -5.00%. Sun Pharma Advanced Research Company had revenue of 271.90M in the quarter ending March 31, 2025, with 64.24% growth.

Revenue

717.70M

Revenue Growth

-5.00%

P/S Ratio

75.01

Revenue / Employee

1.75M

Employees

409

Market Cap

53.84B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	717.70M	-37.75M	-5.00%
Mar 31, 2024	755.45M	-1.63B	-68.36%
Mar 31, 2023	2.39B	1.02B	73.98%
Mar 31, 2022	1.37B	-1.16B	-45.74%
Mar 31, 2021	2.53B	1.76B	229.31%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	525.78B
Divi's Laboratories	93.60B
Cipla	271.45B
Apollo Hospitals Enterprise	217.94B
Zydus Lifesciences	232.42B
Mankind Pharma	122.07B
Aurobindo Pharma	317.24B
Alkem Laboratories	129.65B

Revenue Rankings

Sun Pharma Advanced Research Company News

10 days ago - SPARC shares drop nearly 20% after key drug trial fails - Business Upturn
10 days ago - SPARC shares fall over 13% in trade today: Details here - Business Upturn
3 months ago - Stock Market Today: Rajesh Exports, SCI, RHIM, SPARC, and KEC among top 5 gainers on March 20, 2025 - Business Upturn
6 months ago - SPARC signs binding LOI with UCSF and Tiller Therapeutics for pre-clinical oncology asset - Business Upturn
7 months ago - Sun Pharma Advanced Research Q2 revenue at Rs 12.86 crore; net loss widens to Rs 107.33 crore - Business Upturn

More News